Finance
-
Analysts lift Nvidia targets as AI data-center demand fuels optimism ahead of earnings
Analysts have turned upbeat on Nvidia ahead of its quarterly results, lifting price targets into the low‑to‑mid 200s on continued data‑center momentum and progress toward the GB300 roadmap. Yet a tense regulatory backdrop and China exposure could temper near‑term gains, making the print a key read on whether the AI hardware cycle can sustain its…
-
Tilray Surges on Regulatory Hopes as It Expands Beyond Cannabis
Tilray’s latest move hints at a broader playbook beyond cannabis, with new wellness products and international partnerships on the horizon. Investors are weighing regulatory signals and what diversified growth could mean for margins. A closer look at this evolving strategy reveals how the company aims to balance near-term volatility with longer‑term resilience.
-
Rivian in Hold Pattern as Analysts Eye Profitability Path
Rivian sits in a cautious lane as analysts keep a Hold and targets hover in the mid-teens. The latest quarter hints at revenue growth with a narrowing GAAP loss, but profitability remains a hurdle. Watch for signs of margin recovery and sustained demand ahead.
-
GE Aerospace Rises 35%, Igniting EV/EBITDA Valuation Talk
GE Aerospace has surged recently, outpacing the broad market as investors weigh brighter fundamentals and the potential for higher valuations in the sector. With aviation demand and defense spending on the radar, the rally raises questions about how far the run can go for aerospace stocks.
-
Markets Open Cautiously Ahead of Powell Speech and Walmart Earnings
Markets start the week cautious as investors eye Powell’s remarks and a batch of key earnings. Evercore’s note on CrowdStrike adds a cautionary undertone, while Palo Alto Networks prepares to report in a challenging cybersecurity cycle. A diversified, disciplined stance across consumer and security names could shape the week ahead.
-
Philippines weighs bold crypto reserve to tackle national debt
Could a nation bolt Bitcoin into its financial defenses? A bold legislative proposal would create a government-run crypto reserve, locked for 20 years and dedicated solely to paying down debt. With cold storage, audits, and tight governance, this plan tests how far digital assets can reshape national finance.
-
Robinhood Expands Prediction Markets to NFL and College Football — Rolling Out Soon
Football season just got a new layer for traders. Robinhood is expanding its prediction markets to include professional and college football, with a phased rollout timed to kickoff and weekly additions on the way. A bold move in its quest to be an all-in-one trading platform.
-
Ethereum Set to Lead the Next Crypto Cycle, Hayes Says—Can Solana Catch Up?
Ethereum appears poised to lead the next crypto cycle as liquidity and institutional demand tilt the odds in ETH’s favor. Solana isn’t left out, but the expectation is for ETH to outperform on a percentage basis. Three pillars—positioning, flows, and trajectory—frame the case for a potential ETH-driven rally as the cycle unfolds.
-
ETF-Fueled Ethereum Rally Faces Early Profit-Taking Signals
– Ethereum rides a fresh rally on ETF demand and sturdy on-chain signals, but early profit-taking and looming macro data could spark a pause. Will the momentum hold? – ETH has extended gains on institutional inflows, yet signs of near-term cooling are emerging ahead of key inflation and policy events. – A powerful ETH rally…
-
Bitcoin Holds at Key 112,500 Ahead of Powell Speech
Bitcoin sits just above a key 112,500 support as markets brace for Powell’s Jackson Hole remarks. With hedging and options activity on the move, a dovish read could spark a short-term relief rally, while hawkish signals might keep the downside pressure in play.
-
QQQ Rides AI & Cloud Boom to Fresh Highs
AI-driven momentum is driving tech stocks to fresh highs in 2025. A quick look at the forces behind the rally—from chipmakers to cloud leaders—and what it could mean for a long-term growth strategy in tech.
-
Morgan Stanley raises Nio price target on Onvo momentum
An influential analyst boosts Nio’s target on optimism around restructuring and the new Onvo brand. While near-term hurdles remain, the setup hints at improving margins and a clearer path to profitability as Onvo gains traction.
-
Powell to Set Fed Course at Jackson Hole as Global Policy Leaders Gather
Powell’s Jackson Hole appearance could signal the Fed’s next move as a global policy audience watches closely. With labor markets shifting and inflation in focus, the path for rates in the coming months remains under debate—while an international perspective from Lagarde adds to the tension. A hints-at-answers moment that could move markets.
-
Snowflake Stock in Focus as Analysts Diverge and Insiders Sell
Snowflake sits in the mid-190s as analysts send mixed signals and insiders trim stakes. Revenue growth is clear, but profitability remains a hurdle, shaping a cautious near-term backdrop ahead of the next results.
-
Palantir Climbs as Q2 Results Ignite Growth Potential
Palantir’s latest earnings rally has investors eyeing a potential turn toward durable, profitable growth. With government and enterprise demand fueling revenue momentum, the next leg will hinge on margins and cash flow translating into sustained profitability.
-
Palantir Short Trade Backfires as Price Action Defies Fundamentals
A Palantir trade that didn’t go as planned shows how momentum can outrun fundamentals in the short run. Explore the risk-management lessons and what this means for navigating volatile tech names when sentiment shifts.
-
SUI Dips as Swiss Bank Backing and ETF Filing Sparks Debate
SUI faces a tug-of-war between fresh institutional traction and softer price action. A Swiss bank partnership and an ETF filing signal ambition, but momentum remains mixed as traders eye critical levels. The coming days could reveal whether the institution-led narrative can translate into a sustained move or keep markets range-bound.
-
Novo Nordisk Stock Pullback: Is This a Long-Term Entry Point for a Quality Diabetes Leader?
Novo Nordisk has pulled back even as its diabetes and obesity franchises stay durable. A value‑oriented, fundamentals‑first view weighs long‑term cash flow and credible competitive advantages against a complex growth path, spotlighting a patient-entry thesis for investors who value quality earnings over headlines.
-
Invesco Boosts Samsara Stake as Insiders Sell and Analysts Weigh In
Big investors are upping their Samsara exposure as Invesco boosts its stake while insiders reposition shares. The company posted revenue growth and beat earnings expectations, yet profitability remains a hurdle with negative margins and an uncertain outlook. Analysts are broadly mixed but increasingly constructive, with several price targets nudging higher. Ongoing insider activity and expanding…
-
XRP Signals Caution as Weekly RSI Divergence Meets Range-Bound Trading
XRP is sending mixed signals this week: a weekly RSI divergence hints momentum could wane even as price edges higher. The near-term range sits roughly between $2.90 and $3.40, with a breakout above $3.40 or a break below $2.90 likely signaling the next move. Watch for volume clues and tighter risk controls as the chart…
-
Tonix Awaits FDA Decision on TNX-102 SL Fibromyalgia Drug
Tonix’s fate could hinge on a FDA decision today for TNX-102 SL, a novel non-opioid, sublingual treatment for fibromyalgia. If approved, it could mark a first-in-class approach and reshape the company’s near-term trajectory. The ruling has potential implications for patients and the broader treatment landscape.